Finally, we explore whether the observed changes in gene expression levels of HSP90, HSP60 and GDNF in MS patients compared to the control group are connected to parallel alterations in the levels of the proteins expressed by these genes (Figure 3). Here, HSP90AA1 is linked to myeloid sarcoma.